# Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

> **NCT02324608** · NA · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 15 (actual)

## Conditions studied

- Recurrent Skin Cancer
- Squamous Cell Carcinoma of the Skin

## Interventions

- **BIOLOGICAL:** cetuximab
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02324608
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-30
- **Primary completion:** 2020-12-09
- **Final completion:** 2023-05-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-12-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324608, "Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02324608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*